177 related articles for article (PubMed ID: 32784212)
1. The WHO Global Benchmarking Tool: a game changer for strengthening national regulatory capacity.
Guzman J; O'Connell E; Kikule K; Hafner T
BMJ Glob Health; 2020 Aug; 5(8):. PubMed ID: 32784212
[TBL] [Abstract][Full Text] [Related]
2. The World Health Organization Global Benchmarking Tool an Instrument to Strengthen Medical Products Regulation and Promote Universal Health Coverage.
Khadem Broojerdi A; Baran Sillo H; Ostad Ali Dehaghi R; Ward M; Refaat M; Parry J
Front Med (Lausanne); 2020; 7():457. PubMed ID: 32974367
[TBL] [Abstract][Full Text] [Related]
3. Leveraging WHO's Global Benchmarking Tool to strengthen capacity in clinical trials oversight for public health emergencies: the GHPP VaccTrain model.
Owusu Sekyere S; Škrnjug-Yudov I; Ateba Ngoa U; Juárez Hernández M; Abiri OT; Komeh JP; Janneh Kaira M; Marenah E; Kercula JD; Smith K; Rassokhina O; Meyer H; Conrad C
Global Health; 2022 Jun; 18(1):63. PubMed ID: 35725614
[TBL] [Abstract][Full Text] [Related]
4. Making the investment case for national regulatory authorities.
Twesigye G; Hafner T; Guzman J
J Pharm Policy Pract; 2021 Jan; 14(1):16. PubMed ID: 33478590
[TBL] [Abstract][Full Text] [Related]
5. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
[TBL] [Abstract][Full Text] [Related]
6. Worldwide Assessment of Low- and Middle-Income Countries' Regulatory Preparedness to Approve Medical Products During Public Health Emergencies.
Khadem Broojerdi A; Alfonso C; Ostad Ali Dehaghi R; Refaat M; Sillo HB
Front Med (Lausanne); 2021; 8():722872. PubMed ID: 34485350
[No Abstract] [Full Text] [Related]
7. Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.
Roth L; Bempong D; Babigumira JB; Banoo S; Cooke E; Jeffreys D; Kasonde L; Leufkens HGM; Lim JCW; Lumpkin M; Mahlangu G; Peeling RW; Rees H; Ndomondo-Sigonda M; Stergachis A; Ward M; Nwokike J
Global Health; 2018 Nov; 14(1):102. PubMed ID: 30382856
[TBL] [Abstract][Full Text] [Related]
8. A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency.
Keyter A; Salek S; Banoo S; Walker S
Int J Health Policy Manag; 2022 Jun; 11(6):795-809. PubMed ID: 33300773
[TBL] [Abstract][Full Text] [Related]
9. The capacity of young national medicine regulatory authorities to ensure the quality of medicines: case of Rwanda.
Shabani JBB; Kayitare E; Nyirimigabo E; Habyalimana V; Murindahabi MM; Ntirenganya L; Irasabwa C; Rutungwa E; Munyangaju JE; Hahirwa I
J Pharm Policy Pract; 2022 Nov; 15(1):90. PubMed ID: 36434730
[TBL] [Abstract][Full Text] [Related]
10. Regulation of blood services in Africa.
Ansah JK; Kafere C; Loua A; Nkansah E; Acquah ME; Mudyiwenyama L
Transfus Clin Biol; 2021 May; 28(2):148-153. PubMed ID: 33516886
[TBL] [Abstract][Full Text] [Related]
11. Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency.
Ncube BM; Dube A; Ward K
Pharmaceut Med; 2022 Apr; 36(2):83-97. PubMed ID: 35380413
[TBL] [Abstract][Full Text] [Related]
12. Global pharmaceutical regulation: the challenge of integration for developing states.
Pezzola A; Sweet CM
Global Health; 2016 Dec; 12(1):85. PubMed ID: 27998293
[TBL] [Abstract][Full Text] [Related]
13. Identifying and costing common gaps in Central and West Africa pharmaceutical regulation.
Alfonso CP; N'Jambong GB; Magdy A; Di Trapani L; Kuwana R; Kahsay AG; Maïga D; Ossei-Agyeman-Yeboah SNA; Djitafo Fah AB; Ndomondo-Sigonda M
Front Med (Lausanne); 2024; 11():1362253. PubMed ID: 38660423
[TBL] [Abstract][Full Text] [Related]
14. [Strengthening health regulation in the Americas: regulatory authorities of regional reference].
Ojeda LP; Cristiá RP
Rev Panam Salud Publica; 2016 May; 39(5):294-298. PubMed ID: 27706406
[TBL] [Abstract][Full Text] [Related]
15. The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the World Health Organization Global Benchmarking Tool standards.
Shi J; Chen X; Hu H; Ung COL
Cytotherapy; 2024 Apr; ():. PubMed ID: 38739075
[TBL] [Abstract][Full Text] [Related]
16. Addressing the challenges of regulatory systems strengthening in small states.
Preston C; Freitas Dias M; Peña J; Pombo ML; Porrás A
BMJ Glob Health; 2020; 5(2):e001912. PubMed ID: 32180997
[TBL] [Abstract][Full Text] [Related]
17. WHO collaborative registration procedure using stringent regulatory authorities' medicine evaluation: reliance in action?
Vaz A; Roldão Santos M; Gwaza L; Mezquita González E; Pajewska Lewandowska M; Azatyan S; Saint-Raymond A
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):11-17. PubMed ID: 35130803
[TBL] [Abstract][Full Text] [Related]
18. Capacity for a global vaccine safety system: the perspective of national regulatory authorities.
Graham JE; Borda-Rodriguez A; Huzair F; Zinck E
Vaccine; 2012 Jul; 30(33):4953-9. PubMed ID: 22658930
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
